News & Updates

Treatment outcomes for nAMD, DMO, RVO poorer in clinical practice than in trials
Treatment outcomes for nAMD, DMO, RVO poorer in clinical practice than in trials
13 Jun 2022

In clinical practice, patients with neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO), and retinal vein occlusion (RVO) see treatment outcomes that are inferior to those reported in pivotal phase 3 studies, according to a recent study.

Treatment outcomes for nAMD, DMO, RVO poorer in clinical practice than in trials
13 Jun 2022
Infection + vaccination = The best protection against COVID-19?
Infection + vaccination = The best protection against COVID-19?
13 Jun 2022
CREATE: ‘Open-source’ automated insulin delivery gets good results in T1D
CREATE: ‘Open-source’ automated insulin delivery gets good results in T1D
13 Jun 2022
Limited health literacy tied to low knowledge on SLE
Limited health literacy tied to low knowledge on SLE
13 Jun 2022

Limited health literacy among patients with systemic lupus erythematosus (SLE) contributes to lower knowledge about the disease, a study has shown. The Lupus Knowledge Assessment Test (LKAT) may be improved and used as a screening tool to identify those with knowledge gaps.

Limited health literacy tied to low knowledge on SLE
13 Jun 2022
Weight loss boosts quality of life in type 2 diabetes
Weight loss boosts quality of life in type 2 diabetes
13 Jun 2022 byTristan Manalac

Patients with type 2 diabetes (T2D) who lose more weight appear to have better quality of life (QoL), an effect that is independent of treatments received, according to a study presented at the recent 82nd Scientific Sessions by the American Diabetes Association (ADA 2022).

Weight loss boosts quality of life in type 2 diabetes
13 Jun 2022